ZDA
Zweig-DiMenna Associates Portfolio holdings
AUM
$975M
This Quarter Return
-7.34%
1 Year Return
+47.58%
3 Year Return
+240.4%
5 Year Return
+521.78%
10 Year Return
+1,795.2%
AUM
$2.09B
AUM Growth
+$2.09B
(+18%)
Cap. Flow
+$498M
Cap. Flow
% of AUM
23.88%
Top 10 Holdings %
Top 10 Hldgs %
27.58%
Holding
320
New
75
Increased
75
Reduced
52
Closed
105
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$84.9M |
| 2 |
AGN
Allergan plc
AGN
|
$44.6M |
| 3 |
CELG
Celgene Corp
CELG
|
$42.6M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$33.6M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$32.4M |
Top Sells
| 1 |
BHI
Baker Hughes
BHI
|
$32.1M |
| 2 |
Alibaba
BABA
|
$25M |
| 3 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
$23.5M |
| 4 |
Applied Materials
AMAT
|
$18.9M |
| 5 |
Boeing
BA
|
$18.7M |
Sector Composition
| 1 | Healthcare | 25.65% |
| 2 | Consumer Discretionary | 14.3% |
| 3 | Communication Services | 10.89% |
| 4 | Technology | 9.89% |
| 5 | Consumer Staples | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHI
1
DELISTED
Baker Hughes
BHI
| $111M | 4.79% | 2,123,584 -616,802 | -23% | -$32.1M |
|
|
2
Bristol-Myers Squibb
BMY
$96B
| $85.5M | 3.7% | 1,443,723 +1,433,653 | +14,237% | +$84.9M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $72.8M | 3.15% | 267,660 +164,040 | +158% | +$44.6M |
|
4
HCA Healthcare
HCA
$94.5B
| $48.7M | 2.11% | 630,011 +325,726 | +107% | +$25.2M |
|
5
Visa
V
$683B
| $45.7M | 1.98% | 655,632 +32,872 | +5% | +$2.29M |
|
6
Alphabet (Google) Class C
GOOG
$2.58T
| $45.1M | 1.95% | 72,359 +7,514 | +12% | +$4.68M |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $42.6M | 1.85% | +394,282 | New | +$42.6M |
|
8
Amazon
AMZN
$2.44T
| $41.8M | 1.81% | 81,744 +35,568 | +77% | +$18.2M |
|
9
Meta Platforms (Facebook)
META
$1.86T
| $41.3M | 1.79% | 459,718 +25,860 | +6% | +$2.32M |
|
10
Booking.com
BKNG
$181B
| $41.3M | 1.79% | 33,376 -292 | -0.9% | -$361K |
|
|
TWX
11
DELISTED
Time Warner Inc
TWX
| $40.4M | 1.75% | 587,440 -71,735 | -11% | -$4.93M |
|
|
12
Vertex Pharmaceuticals
VRTX
$100B
| $35.2M | 1.53% | 338,441 +311,441 | +1,153% | +$32.4M |
|
|
ALXN
13
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $33.6M | 1.46% | +214,946 | New | +$33.6M |
|
14
Bausch Health
BHC
$2.74B
| $33.3M | 1.44% | 186,798 +42,071 | +29% | +$7.5M |
|
15
Danaher
DHR
$147B
| $32.4M | 1.4% | 379,855 +25,491 | +7% | +$2.17M |
|
16
BioMarin Pharmaceuticals
BMRN
$11.2B
| $31.2M | 1.35% | 296,065 +243,565 | +464% | +$25.7M |
|
|
APC
17
DELISTED
Anadarko Petroleum
APC
| $30M | 1.3% | 495,997 +41,573 | +9% | +$2.51M |
|
18
Sealed Air
SEE
$4.78B
| $29.6M | 1.28% | 630,657 +151,778 | +32% | +$7.12M |
|
|
WBA
19
DELISTED
Walgreens Boots Alliance
WBA
| $29.4M | 1.27% | +353,698 | New | +$29.4M |
|
|
BERY
20
DELISTED
Berry Global Group, Inc.
BERY
| $28.5M | 1.24% | 949,043 +329,100 | +53% | +$9.9M |
|
|
DATA
21
DELISTED
Tableau Software, Inc.
DATA
| $28.2M | 1.22% | +353,748 | New | +$28.2M |
|
22
Apple
AAPL
$3.45T
| $27.8M | 1.21% | 252,439 +28,689 | +13% | +$3.16M |
|
|
SCU
23
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $27.4M | 1.19% | 3,135,762 +776,975 | +33% | +$6.78M |
|
24
Hilton Worldwide
HLT
$64.9B
| $27.2M | 1.18% | 1,184,270 -153,659 | -11% | -$3.52M |
|
25
Chubb
CB
$110B
| $26.8M | 1.16% | +259,306 | New | +$26.8M |
|